Blog - Page 3017 of 5693

TuesdayJun 04, 2013 10:16 am

Pixelworks (PXLW) to Debut Innovative Tablet and Ultrabook Display Processor Technology at COMPUTEX TAIPEI

Pixelworks, Inc., creator, developer and marketer of video display processing technology for digital video applications, announced today that is cutting edge video display will soon be featured in Tablets and Ultrabooks. The company will demonstrate its technology for the highest quality video at invitation-only meetings at this year’s COMPUTEX TAIPEI. Specifically, Pixelworks’ demonstrations will be on Windows 8™ Tablets and Ultrabooks based on Intel’s 4th generation Core™ processors. Users are beginning to demand the highest image quality for their movies, photos and video games on every screen that they choose to consume media. Utilizing an innovative new process, Pixelworks is…

TuesdayJun 04, 2013 10:09 am

ImmuDyne (IMMD) to Launch Proprietary Product to Curb Hangovers

ImmuDyne, a health and wellness lifestyle company with a portfolio of patented products with applications in the wellness lifestyle, skin care, anti-aging, fitness and health markets, today unveiled its plans to launch a new, proprietary dietary supplement in the U.S. alcohol consumption and hangover markets. The company notes that approximately 1 in 6 adults binge drink, consuming an average of four to eight alcoholic beverage four or more times a month, according to a 2010 report published by the Centers for Disease Control and Prevention (CDC). In January of 2013, the CDC released the findings of another study demonstrating that…

TuesdayJun 04, 2013 9:43 am

Arno Therapeutics (ARNI) Enters into Collaboration with Veridex to Develop Diagnostic Test

Arno Therapeutics, a clinical stage biopharmaceutical company developing innovative products for the treatment of cancer, has signed an agreement with Veridex, LLC, a Johnson & Johnson company, for the development of a diagnostic test to help identify patients that could potentially benefit from treatment with anti-progestinssuch asonapristone, ArnoTherapeutics’ orally administered, investigational type 1 progestin receptor antagonist. The collaboration will allow Arno Therapeutics to utilize CELLSEARCH®, Veridex's proprietary technology that uses an advanced cell separation technique to isolate CTCs and further analyze the cells for the presence of APR. The CELLSEARCH® CTC System is the first and only standardized, FDA-cleared, semi-automated system…

MondayJun 03, 2013 5:58 pm

GNCC Capital, Inc. (GNCP) Burnt Wells Summary

Gold and silver exploration and marketing company GNCC Capital holds a number of properties in Arizona that it plans to develop through the use of exploration, testing, and joint ventures. One of their major properties is Burnt Well Gold Properties, roughly 50 miles northwest of Phoenix. It consists of 9 unpatented lode mining claims, covering approximately 160 acres in the Harcuvar Mining District, near Wenden, Arizona. Burnt Well is a former Cordex Exploration Company project, and includes the historic Silver Lining Mine. The land is administered by the U.S. Bureau of Land Management. Burnt Well already has a number…

MondayJun 03, 2013 1:46 pm

Solar Wind Energy Tower, Inc. (SWET) Details Downdraft Tower Technology in QualityStocks Audio Interview

Solar Wind Energy Tower is the developer of a single large Solar Wind Downdraft Tower structure that produces renewable, cost-effective electricity without the restraints other alternative energies may face. Company CEO Ronald W. Pickett was recently featured in an audio interview with QualityStocks in which he provides a sweeping review of the company’s technology and applications to the energy industry. The interview can be heard at http://dtg.fm/SWET-Interview-06-13. In the interview, Pickett discusses the capabilities of the company's Solar Wind Downdraft Tower, how its structure has evolved, as well as supporting patents. He also details current and potential projects with facilities…

MondayJun 03, 2013 1:45 pm

ScripsAmerica, Inc. (SCRC) Begins Negotiations, Strategy Talks to Distribute RapiMed Products in China

ScripsAmerica, a supplier of prescription and OTC drugs, has entered into talks with Forbes Investment Ltd. to market, supply, distribute and adapt ScripsAmerica’s RapiMed® products throughout China. Jun Liang, manager of Forbes Ltd. in Shenzhen, China, is making arrangements for ScripsAmerica to meet with the investment group’s pharmacy and hospital buying networks as part of an upcoming sales agreement that would introduce RapiMed into the Chinese OTC drug market. “ScripsAmerica's RapiMed Products are uniquely formulated to meet China's market needs. It allows the country's pharmaceutical companies, hospitals, nursing facilities, research institutes and the military to adapt RapiMed to fit their…

MondayJun 03, 2013 1:44 pm

Polar Petroleum Corp. (POLR) Acquires 100% Stake in 12 Offshore Oil & Gas Leases

Polar Petroleum, an independent American oil and gas company based in Anchorage, Alaska, has completed its acquisition of a 100 percent working interest in 12 offshore oil and gas leases (collectively, the North Point Thomson Project) in Alaska's prolific North Slope region. "By acquiring the North Point Thomson Project, we have established a presence in a third area marked by significant Alaska energy industry production, activity and development involving major industry players,” Polar Petroleum president and CEO Daniel Walker statedin the press release. “Our next steps will include drawing on the insights of the surrounding historic exploration to plan an…

MondayJun 03, 2013 1:44 pm

Polar Petroleum Corp. (POLR) Acquires 100% Stake in 12 Offshore Oil & Gas Leases

MondayJun 03, 2013 1:43 pm

Marathon Patent Group, Inc. (MARA) Raises $6.0 Million; Allocated to Fund Operations, Potential Patent Acquisitions

Marathon Patent Group, an intellectual property services and patent licensing company, has received $6.0 million in subscriptions for units offered in a privately subscribed offering at $0.40 per Unit, with each unit consisting of one share of common stock and a three-year warrant to purchase one-half of one share of common stock at an exercise price of $0.50 per share. The company said it plans to use the net proceeds from this offering to fund operations, and willcontinue to seek strategic IP asset acquisitions such as revenue-producing patents and portfolios. "The recent financing will strengthen Marathon's balance sheet and facilitate…

MondayJun 03, 2013 1:39 pm

Hemp, Inc. (HEMP) Increases Q1 2013 Revenue by 4,785% vs. Q4 2012

Hemp, Inc.is a supplier of services, products, and information related to the medical marijuana industry. The company today reported it has increased its first-quarter revenue by 4,785 percent to $426,321 as compared to fourth-quarter revenues. The main contributor to sales was the company’s Nutraceutical division, which features the company’s HerbaGenix™ brand of all-natural herbal products that contain hemp and hemp extracts. After generating a steady sales stream for its hemp-based Nutraceutical division, Hemp says it will now focus on strengthening its other divisions by growing advertising revenue from severalWebsites and its industry consulting company, The Industrial Hemp and Medical Marijuana…

Site Search

Company Search

Pixelworks (PXLW) to Debut Innovative Tablet and Ultrabook Display Processor Technology at COMPUTEX TAIPEI

ImmuDyne (IMMD) to Launch Proprietary Product to Curb Hangovers

Arno Therapeutics (ARNI) Enters into Collaboration with Veridex to Develop Diagnostic Test

GNCC Capital, Inc. (GNCP) Burnt Wells Summary

Solar Wind Energy Tower, Inc. (SWET) Details Downdraft Tower Technology in QualityStocks Audio Interview

ScripsAmerica, Inc. (SCRC) Begins Negotiations, Strategy Talks to Distribute RapiMed Products in China

Polar Petroleum Corp. (POLR) Acquires 100% Stake in 12 Offshore Oil & Gas Leases

Polar Petroleum Corp. (POLR) Acquires 100% Stake in 12 Offshore Oil & Gas Leases

Marathon Patent Group, Inc. (MARA) Raises $6.0 Million; Allocated to Fund Operations, Potential Patent Acquisitions

Hemp, Inc. (HEMP) Increases Q1 2013 Revenue by 4,785% vs. Q4 2012

Market Basics

Newsletter Publishers

Public Companies